Mango Sciences Inc.
Boston, US · Founded 2019 · Delaware corporation · 3 known investors
Mango Sciences applies AI and data analytics to real-world clinical and healthcare data to improve patient representation and access, and to support life science research and pharmaceutical, MedTech, and CRO customers. The company focuses on real-world evidence and analytics for the global health system industry, with commercial activity in the MENA and APAC regions.
Founders & leadership
HS
Hoicine Sidi-SaidDirector
SE
Sara EapenExecutive Officer
SR
Sanjay ReddyDirector
MM
Mohit MisraFounder
VC
Vamsi Chandra KasivajjalaDirector, Promoter
HK
Hanif Khalak
A
AndyExecutive
G
Gavin
R
RamHead of Strategic Finance
C
Chitrang
NS
Navinder Singh SacharVP of Commercial MENA & APAC
RR
Rohith RajChief People Strategist
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$2.7MraisedJan 2020 · 23 investors · Other TechnologyRule 506(b)
▶$2.7MraisedJan 2020 · 23 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Hoicine Sidi-SaidDirector
- Sara EapenExecutive Officer
- Sanjay ReddyDirector
- Mohit MisraExecutive Officer, Director, Promoter
- Vamsi Chandra KasivajjalaDirector, Promoter
- Offering amount
- $7M
- Amount sold
- $2.7M
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.